Navigation Links
Clinical Outsourcing Leaders Summit Set to Convene November 13
Date:10/2/2008

WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- The Association of Clinical Research Organizations (ACRO) is pleased to announce it will convene the inaugural Clinical Outsourcing Leaders Summit with a select group of senior pharmaceutical, biotech and clinical research executives November 13, 2008 in Washington, DC.

This exclusive event will feature high-level, interactive discussions surrounding the impact of the presidential election on biomedical research and various aspects of drug development. Among the featured speakers are:

Dr. Mark B. McClellan, Senior Fellow and Director of The Engelberg Center for Healthcare Reform at the Brookings Institution and former commissioner of the Food and Drug Administration;

Bill Thomas, former U.S. Congressman and former Chairman of the House Committee on Ways and Means. Currently a Senior Advisor to Buchanan, Ingersoll & Rooney PC and a Visiting Fellow at the American Enterprise Institute;

Dr. Andrew Dahlem, Vice President and COO, Eli Lilly Laboratories;

Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research at the Food and Drug Administration;

Ken Getz, founder and chairman of the nonprofit CISCRP and a Senior Research Fellow at the Tufts Center for Drug Development, Tufts University Medical School;

Chris Singer, Executive Vice President and COO of PhRMA;

David Spaight, Chair of the ACRO Board of Directors and President of MDS Pharma Services;

Dr. Dennis Gillings, founding Chair of ACRO and Chairman and CEO of Quintiles Transnational Corp.

"Regardless of the outcome of the November elections, we know the drug development industry will face significant changes in the coming years," said ACRO Executive Director, Doug Peddicord, Ph.D. "This summit will bring together thought leaders from the biopharmaceutical and clinical outsourcing industries for an open dialogue on the political, economic and regulatory aspects of the changing healthcare landscape."

The Clinical Outsourcing Leaders Summit is open to ACRO members and invited senior executives from the pharmaceutical and biotech industries. To inquire about participating, please contact Jonathan Jagoda at 202.543.4018.

About ACRO

The Association of Clinical Research Organizations (ACRO) is the professional organization of companies whose focus is clinical research. The association provides an active voice for the CRO industry, which provides specialized services that are integral to the development of drugs, biologics, and medical devices. ACRO helps its members improve the quality, efficiency, and safety of biomedical research. For more information, please visit http://www.acrohealth.org.

CONTACTS: Media

John Lewis

+1 202.285.5726

Industry

Jonathan Jagoda

+1 202.543.4018


'/>"/>
SOURCE Association of Clinical Research Organizations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jefferson awarded multi-million dollar grant from National Eye Institute for new clinical trial
2. MultiVu Video Feed: NEW RESEARCH PUBLISHED IN THE AMERICAN JOURNAL OF CLINICAL NUTRITION FINDS PISTACHIOS IMPROVE RISK FACTORS FOR HEART DISEASE
3. What is the clinical features of primary aortoenteric fistula?
4. Medicare HMO costs may prevent cancer patient clinical trial participation
5. DIA Conference to Present Latest Strategies in Clinical Trial Disclosure Compliance
6. Novel tuberculosis vaccine in Germany in clinical phase
7. Adhesion Prevention New Major Market Opportunity, Haemacure Confirms Effectiveness of its Fibrin Sealant in Second Preclinical Study in Adhesion Prevention in a Bleeding Model
8. Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development
9. VCU Massey Cancer Center spearheads novel clinical study for lymphoma patients
10. Shaping Best Practices For Standardized Medical Imaging In Clinical Trials
11. New probe to detect skin cancer receives more funding for clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... ... , ... The Jones Agency, a family owned insurance company with offices serving ... charity drive with the Tarrant Area Food Bank in the hopes of alleviating hunger ... need, the Tarrant County Food Bank offers hope and security to the one in ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Miami Dental Specialists ... to their Miami dental office. Beginning in January, Miami Dental Specialists will offer ... Dental Specialists are the first office to be chosen by the dental implant manufacturer, ...
(Date:2/12/2016)... ... February 12, 2016 , ... Atlantic Information Services, Inc. (AIS) ... PBMs,” an upcoming Feb. 24 webinar that will discuss ways health plans and ... such as the $1,000-per-pill hepatitis C treatment Sovaldi and high-cost PCSK9 inhibitors to ...
(Date:2/12/2016)... ... ... The Central Coast Autism Spectrum Center (CCASC) invites teens ages 11-18 to its annual Winter ... teens with and without special needs to gather in a safe and supportive environment. Volunteers ... will take place on Saturday, Feb. 13 from 7 to 9:30 p.m. at Elks Lodge, ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology: